Kusno Effendi
Kusno Effendi
Verified email at journal.uad.ac.id
Title
Cited by
Cited by
Year
Upregulation of integrin β 4 promotes epithelial–mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma
Y Masugi, K Yamazaki, K Emoto, K Effendi, H Tsujikawa, M Kitago, ...
Laboratory investigation 95 (3), 308-319, 2015
982015
Bmi‐1 gene is upregulated in early‐stage hepatocellular carcinoma and correlates with ATP‐binding cassette transporter B1 expression
K Effendi, T Mori, M Komuta, Y Masugi, W Du, M Sakamoto
Cancer science 101 (3), 666-672, 2010
692010
Reduced transforming growth factor-β receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis
T Mamiya, K Yamazaki, Y Masugi, T Mori, K Effendi, W Du, T Hibi, ...
Laboratory investigation 90 (9), 1339-1345, 2010
622010
Identification by differential tissue proteome analysis of talin-1 as a novel molecular marker of progression of hepatocellular carcinoma
H Kanamori, T Kawakami, K Effendi, K Yamazaki, T Mori, H Ebinuma, ...
Oncology 80 (5-6), 406-415, 2011
612011
Molecular diagnosis of multistage hepatocarcinogenesis
M Sakamoto, K Effendi, Y Masugi
Japanese journal of clinical oncology 40 (9), 891-896, 2010
522010
OATP1B3 expression is strongly associated with Wnt/β-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma
A Ueno, Y Masugi, K Yamazaki, M Komuta, K Effendi, Y Tanami, ...
Journal of hepatology 61 (5), 1080-1087, 2014
512014
Upregulated SMAD3 promotes epithelial–mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma
K Yamazaki, Y Masugi, K Effendi, H Tsujikawa, N Hiraoka, M Kitago, ...
Laboratory investigation 94 (6), 683-691, 2014
502014
Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma
M Sakamoto, T Mori, Y Masugi, K Effendi, I Rie, W Du
Intervirology 51 (Suppl. 1), 42-45, 2008
462008
Leucine-rich repeat-containing G protein-coupled receptor 5 regulates epithelial cell phenotype and survival of hepatocellular carcinoma cells
M Fukuma, K Tanese, K Effendi, K Yamazaki, Y Masugi, M Suda, ...
Experimental cell research 319 (3), 113-121, 2013
442013
Comparative study of Gamma Knife surgery and percutaneous retrogasserian glycerol rhizotomy for trigeminal neuralgia in patients with multiple sclerosis
D Mathieu, K Effendi, J Blanchard, M Séguin
Journal of neurosurgery 117 (Special_Suppl), 175-180, 2012
422012
Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease
Y Masugi, T Abe, H Tsujikawa, K Effendi, A Hashiguchi, M Abe, Y Imai, ...
Hepatology communications 2 (1), 58-68, 2018
362018
Molecular pathology in early hepatocarcinogenesis
K Effendi, M Sakamoto
Oncology 78 (2), 157-160, 2010
342010
Presence of primary cilia in cancer cells correlates with prognosis of pancreatic ductal adenocarcinoma
K Emoto, Y Masugi, K Yamazaki, K Effendi, H Tsujikawa, M Tanabe, ...
Human pathology 45 (4), 817-825, 2014
332014
Involvement of hepatocellular carcinoma biomarker, cyclase-associated protein 2 in zebrafish body development and cancer progression
K Effendi, K Yamazaki, T Mori, Y Masugi, S Makino, M Sakamoto
Experimental cell research 319 (1), 35-44, 2013
252013
Erratum: ‘‘Empty state and filled state image of ZnGa acceptor in GaAs studied by scanning tunneling microscopy’’ [Appl. Phys. Lett. 64, 1836 (1994)]
ZF Zheng, MB Salmeron, ER Weber
Applied Physics Letters 65 (6), 790-790, 1994
22*1994
Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
M Sakamoto, H Tsujikawa, K Effendi, H Ojima, K Harada, Y Zen, F Kondo, ...
Pathology international 67 (1), 1-7, 2017
192017
disseminating your research findings
K Effendi, B Hamber
Research in practice: applied methods for the social sciences, 112, 2006
172006
Overexpression of adenylate cyclase‐associated protein 2 is a novel prognostic marker in malignant melanoma
Y Masugi, K Tanese, K Emoto, K Yamazaki, K Effendi, T Funakoshi, ...
Pathology international 65 (12), 627-634, 2015
162015
Biomarkers and personalized sorafenib therapy
M Kudo, O Matsui, N Izumi, H Iijima, M Kadoya, Y Imai, T Okusaka, ...
Liver cancer 3 (3-4), 399-404, 2014
162014
Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) represents a typical Wnt/β-catenin pathway-activated hepatocellular carcinoma
K Effendi, K Yamazaki, M Fukuma, M Sakamoto
Liver Cancer 3 (3-4), 451-457, 2014
152014
The system can't perform the operation now. Try again later.
Articles 1–20